Jean-Francois Briand

Title: Innovations of Jean-Francois Briand

Introduction

Jean-Francois Briand is a notable inventor based in Saclay, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 2 patents, his work has the potential to impact medical science and patient care.

Latest Patents

Briand's latest patents include innovative piperazinyl derivatives aimed at treating cancer. The first patent discloses piperazinyl derivatives of formula (I) and their use as a drug, specifically for cancer treatment. It also details pharmaceutical compositions that incorporate these derivatives and methods for their synthesis. The second patent relates to compounds of general formula (I) and their pharmaceutically acceptable salts, isomers, and mixtures. This invention emphasizes the use of these compounds as medicaments, particularly for cancer treatment, along with the compositions that contain them.

Career Highlights

Throughout his career, Jean-Francois Briand has worked with various companies, including Marc-Henry Pitty. His expertise in pharmaceutical innovation has positioned him as a key figure in the development of new cancer therapies.

Collaborations

Briand has collaborated with notable coworkers such as Denis Carniato and Mathieu Gutmann. Their combined efforts have contributed to the advancement of research in the pharmaceutical field.

Conclusion

Jean-Francois Briand's work in developing piperazinyl derivatives for cancer treatment showcases his innovative spirit and dedication to improving healthcare. His contributions are significant in the ongoing fight against cancer, and his patents reflect a commitment to advancing medical science.